By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Protagen AG 

Otto Hahn Str. 15

Dortmund    44227  Germany
Phone: 49-231-9742-890 Fax: 49-231-9742-891



Company News
Protagen AG Join Forces With The U.S. National Cancer Institute To Answer Pressing Questions In Immuno-Oncology 2/2/2017 7:14:45 AM
Protagen AG Release: The German National Center For Tumor Diseases (NCT) Heidelberg And Company Investigate Responsiveness To Checkpoint Inhibitors In Melanoma 1/17/2017 12:46:57 PM
Protagen AG Successfully Joined Forces With Novartis AG (NVS) To Support Clinical Development Of A Novel Compound In An Autoimmune Indication 12/20/2016 8:44:35 AM
Protagen AG Launches NavigAID Assay To Support Clinical Drug Development For Autoimmune Diseases 12/14/2016 6:47:09 AM
Protagen AG Launches Navigaid Assay To Support Clinical Drug Development For Autoimmune Diseases 12/13/2016 8:21:26 AM
Protagen AG Inks License Agreement With INOVA Diagnostics For Its Proprietary BICD2 Biomarker 8/11/2016 11:42:27 AM
Protagen AG Appoints Bernhard Kirschbaum As New Chairman And Oliver Schacht As New Board Member 7/20/2016 9:55:18 AM
Protagen AG Announces CE Mark For Its Proprietary Multilisa® BICD2 Test For Better Diagnosis Of Systemic Sclerosis 6/15/2016 7:39:17 AM
Protagen AG Launches First CE Marked Diagnostic Assays Multilisa® CENP-B And Scl-70 For The Diagnosis Of Systemic Sclerosis 5/31/2016 11:09:02 AM
Protagen AG Supports Novel Route To Serum Based Prostate Cancer Diagnostics 2/11/2016 8:26:16 AM